Promising treatment for macular degeneration

 

In trials using mice, a new class of drugs has proven highly effective at helping to reduce the abnormal blood vessels responsible for vision loss associated with AMD.

 

“We may have found an optimized treatment for macular degeneration,” said senior author of the study published in the Journal of Clinical Investigation, Sai Chavala.

 

MDM2 inhibitors are the source of this cautious enthusiasm. While anti-VEGF, presently the most widespread treatment, works by targeting the growth factors that lead to the formation of leaky blood vessels, MDM2 inhibitors attack the blood vessels directly, causing them to regress. This could lead to more long-lasting results.

 

The drug activates a protein called p53, a regulator that determines if a cell lives or dies. This protein initiates the cell death process in the abnormal blood vessels. Another technique, low-dose radiation, also works to increase p53 protein, but it causes DNA damage, which MDM2 doesn’t do.

 

“The idea is we’d like to have a long-lasting treatment so patients wouldn’t have to receive as many injections,” said Chavala. “That would reduce their overall risk of eye infections, and also potentially lower the economic burden of this condition by reducing treatment costs.”

 

Source:

http://news.unchealthcare.org/news/2013/september/unc-research-points-to-promising-treatment-for-macular-degeneration

Featured Posts

Transitions®: the clear lens that adapts to light for the perfect protection!

Did you know Transitions® has a lens for all your patients experiencing any level of light sensitivity?

Learn More

In Perfect Harmony

Dress your eyes in a showstopping synchronous design from VANNI's Tandem collection.

Learn More

Transitions®: the clear lens that adapts to light for the perfect protection!

Did you know Transitions® has a lens for all your patients experiencing any level of light sensitivity?

Read more

SightGlass Vision Releases First White Paper on Diffusion Optics Technology™

SightGlass Vision announced the release of its first white paper regarding the company’s Diffusion Optics Technology™ (DOT 0.2) spectacle lenses.

Read more

Companies Nominated at the 30th SILMO d’Or

The 2023 SILMO d'Or nominees are...

Read more

Nicolas Fafiotte Appointed President of the 2023 SILMO D’OR Awards

A graduate of the ESMOD School of Fashion Design, Nicolas Fafiotte trained in Paris before moving to Lyon in the early 2000s.

Read more

Transitions®: the clear lens that adapts to light for the perfect protection!

Did you know Transitions® has a lens for all your patients experiencing any level of light sensitivity?

Learn More

In Perfect Harmony

Dress your eyes in a showstopping synchronous design from VANNI's Tandem collection.

Learn More

Transitions®: the clear lens that adapts to light for the perfect protection!

Did you know Transitions® has a lens for all your patients experiencing any level of light sensitivity?

Read More

SightGlass Vision Releases First White Paper on Diffusion Optics Technology™

SightGlass Vision announced the release of its first white paper regarding the company’s Diffusion Optics Technology™ (DOT 0.2) spectacle lenses.

Read More

Companies Nominated at the 30th SILMO d’Or

The 2023 SILMO d'Or nominees are...

Read More

Nicolas Fafiotte Appointed President of the 2023 SILMO D’OR Awards

A graduate of the ESMOD School of Fashion Design, Nicolas Fafiotte trained in Paris before moving to Lyon in the early 2000s.

Read More

Transitions®: the clear lens that adapts to light for the perfect protection!

Did you know Transitions® has a lens for all your patients experiencing any level of light sensitivity?

Learn More

In Perfect Harmony

Dress your eyes in a showstopping synchronous design from VANNI's Tandem collection.

Learn More

Transitions®: the clear lens that adapts to light for the perfect protection!

Did you know Transitions® has a lens for all your patients experiencing any level of light sensitivity?

Read more

SightGlass Vision Releases First White Paper on Diffusion Optics Technology™

SightGlass Vision announced the release of its first white paper regarding the company’s Diffusion Optics Technology™ (DOT 0.2) spectacle lenses.

Read more

Companies Nominated at the 30th SILMO d’Or

The 2023 SILMO d'Or nominees are...

Read more

Nicolas Fafiotte Appointed President of the 2023 SILMO D’OR Awards

A graduate of the ESMOD School of Fashion Design, Nicolas Fafiotte trained in Paris before moving to Lyon in the early 2000s.

Read more

Transitions®: the clear lens that adapts to light for the perfect protection!

Did you know Transitions® has a lens for all your patients experiencing any level of light sensitivity?

Learn More

In Perfect Harmony

Dress your eyes in a showstopping synchronous design from VANNI's Tandem collection.

Learn More

Transitions®: the clear lens that adapts to light for the perfect protection!

Did you know Transitions® has a lens for all your patients experiencing any level of light sensitivity?

Read more

SightGlass Vision Releases First White Paper on Diffusion Optics Technology™

SightGlass Vision announced the release of its first white paper regarding the company’s Diffusion Optics Technology™ (DOT 0.2) spectacle lenses.

Read more

Companies Nominated at the 30th SILMO d’Or

The 2023 SILMO d'Or nominees are...

Read more

Nicolas Fafiotte Appointed President of the 2023 SILMO D’OR Awards

A graduate of the ESMOD School of Fashion Design, Nicolas Fafiotte trained in Paris before moving to Lyon in the early 2000s.

Read more